112 related articles for article (PubMed ID: 10483259)
1. [Autoantibody against Na+/I- symporter (NaIS)].
Zeki K
Nihon Rinsho; 1999 Aug; 57(8):1824-8. PubMed ID: 10483259
[TBL] [Abstract][Full Text] [Related]
2. Autoantibody against Na+/I- symporter in the sera of patients with autoimmune thyroid disease.
Endo T; Kogai T; Nakazato M; Saito T; Kaneshige M; Onaya T
Biochem Biophys Res Commun; 1996 Jul; 224(1):92-5. PubMed ID: 8694839
[TBL] [Abstract][Full Text] [Related]
3. Autoantibodies from patients with autoimmune thyroid disease do not interfere with the activity of the human iodide symporter gene stably transfected in CHO cells.
Tonacchera M; Agretti P; Ceccarini G; Lenza R; Refetoff S; Santini F; Pinchera A; Chiovato L; Vitti P
Eur J Endocrinol; 2001 Jun; 144(6):611-8. PubMed ID: 11375795
[TBL] [Abstract][Full Text] [Related]
4. Autoantibody against thyroid iodide transporter in the sera from patients with Hashimoto's thyroiditis possesses iodide transport inhibitory activity.
Endo T; Kaneshige M; Nakazato M; Kogai T; Saito T; Onaya T
Biochem Biophys Res Commun; 1996 Nov; 228(1):199-202. PubMed ID: 8912659
[TBL] [Abstract][Full Text] [Related]
5. Detection of binding and blocking autoantibodies to the human sodium-iodide symporter in patients with autoimmune thyroid disease.
Ajjan RA; Kemp EH; Waterman EA; Watson PF; Endo T; Onaya T; Weetman AP
J Clin Endocrinol Metab; 2000 May; 85(5):2020-7. PubMed ID: 10843191
[TBL] [Abstract][Full Text] [Related]
6. Low frequency of autoantibodies to the human Na(+)/I(-) symporter in patients with autoimmune thyroid disease.
Seissler J; Wagner S; Schott M; Lettmann M; Feldkamp J; Scherbaum WA; Morgenthaler NG
J Clin Endocrinol Metab; 2000 Dec; 85(12):4630-4. PubMed ID: 11134119
[TBL] [Abstract][Full Text] [Related]
7. Rarity of anti- Na+/I- symporter (NIS) antibody with iodide uptake inhibiting activity in autoimmune thyroid diseases (AITD).
Chin HS; Chin DK; Morgenthaler NG; Vassart G; Costagliola S
J Clin Endocrinol Metab; 2000 Oct; 85(10):3937-40. PubMed ID: 11061560
[TBL] [Abstract][Full Text] [Related]
8. Differential autoantibody responses to thyroid peroxidase in patients with Graves' disease and Hashimoto's thyroiditis.
Bermann M; Magee M; Koenig RJ; Kaplan MM; Arscott P; Maastricht J; Johnson J; Baker JR
J Clin Endocrinol Metab; 1993 Oct; 77(4):1098-101. PubMed ID: 8408460
[TBL] [Abstract][Full Text] [Related]
9. The immune response to the iodide transporter.
Spitzweg C; Morris JC
Endocrinol Metab Clin North Am; 2000 Jun; 29(2):389-98, viii. PubMed ID: 10874536
[TBL] [Abstract][Full Text] [Related]
10. Cloning and characterization of the novel thyroid and eye muscle shared protein G2s: autoantibodies against G2s are closely associated with ophthalmopathy in patients with Graves' hyperthyroidism.
Gunji K; De Bellis A; Li AW; Yamada M; Kubota S; Ackrell B; Wengrowicz S; Bellastella A; Bizzarro A; Sinisi A; Wall JR
J Clin Endocrinol Metab; 2000 Apr; 85(4):1641-7. PubMed ID: 10770210
[TBL] [Abstract][Full Text] [Related]
11. Anterior pituitary cell antibodies detected in Hashimoto's thyroiditis and Graves' disease.
Kobayashi I; Inukai T; Takahashi M; Ishii A; Ohshima K; Mori M; Shimomura Y; Kobayashi S; Hashimoto A; Sugiura M
Endocrinol Jpn; 1988 Oct; 35(5):705-8. PubMed ID: 3220050
[TBL] [Abstract][Full Text] [Related]
12. Autoimmunity involving the human sodium/iodide symporter: fact or fiction?
Heufelder AE; Joba W; Morgenthaler NG
Exp Clin Endocrinol Diabetes; 2001; 109(1):35-40. PubMed ID: 11573137
[TBL] [Abstract][Full Text] [Related]
13. The modulation of the human sodium iodide symporter activity by Graves' disease sera.
Ajjan RA; Findlay C; Metcalfe RA; Watson PF; Crisp M; Ludgate M; Weetman AP
J Clin Endocrinol Metab; 1998 Apr; 83(4):1217-21. PubMed ID: 9543144
[TBL] [Abstract][Full Text] [Related]
14. Pendrin is a novel autoantigen recognized by patients with autoimmune thyroid diseases.
Yoshida A; Hisatome I; Taniguchi S; Shirayoshi Y; Yamamoto Y; Miake J; Ohkura T; Akama T; Igawa O; Shigemasa C; Kamijo K; Ikuyama S; Caturegli P; Suzuki K
J Clin Endocrinol Metab; 2009 Feb; 94(2):442-8. PubMed ID: 19050049
[TBL] [Abstract][Full Text] [Related]
15. Identification of antigenic domains on the human sodium-iodide symporter which are recognized by autoantibodies from patients with autoimmune thyroid disease.
Kemp EH; Waterman EA; Ajjan RA; Smith KA; Watson PF; Ludgate ME; Weetman AP
Clin Exp Immunol; 2001 Jun; 124(3):377-85. PubMed ID: 11472397
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies to glutamic acid decarboxylase in patients with autoimmune thyroid disease: relation to competitive insulin autoantibodies.
Kawasaki E; Abiru N; Yano M; Uotani S; Matsumoto K; Matsuo H; Yamasaki H; Yamamoto H; Yamaguchi Y; Akazawa S
J Autoimmun; 1995 Oct; 8(5):633-43. PubMed ID: 8579720
[TBL] [Abstract][Full Text] [Related]
17. Increased serum concentration of soluble CD30 in patients with Graves' disease and Hashimoto's thyroiditis.
Okumura M; Hidaka Y; Kuroda S; Takeoka K; Tada H; Amino N
J Clin Endocrinol Metab; 1997 Jun; 82(6):1757-60. PubMed ID: 9177377
[TBL] [Abstract][Full Text] [Related]
18. The thyroid "microsomal" antigen is an epitope on the thyrotropin receptor.
Islam N; Tuppal R; Hawe BS; Briones-Urbina R; Farid NR
J Cell Biochem; 1986; 31(2):107-20. PubMed ID: 2426288
[TBL] [Abstract][Full Text] [Related]
19. Association of HLA antigen and restriction fragment length polymorphism of T cell receptor beta-chain gene with Graves' disease and Hashimoto's thyroiditis.
Ito M; Tanimoto M; Kamura H; Yoneda M; Morishima Y; Yamauchi K; Itatsu T; Takatsuki K; Saito H
J Clin Endocrinol Metab; 1989 Jul; 69(1):100-4. PubMed ID: 2567295
[TBL] [Abstract][Full Text] [Related]
20. Normal immunoregulation of in vitro antibody secretion in autoimmune thyroid disease.
MacLean DB; Miller KB; Brown R; Reichlin S
J Clin Endocrinol Metab; 1981 Oct; 53(4):801-5. PubMed ID: 6457056
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
